Cat.#: ASSD-138
| Description | A3AR covalent antagonist.Binds irreversibly. Apparent pKi values at A3ARs are 6.9 and 8.0 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-(8-Methoxy-2,4-dioxo-3-propylpurino[7,8-a]pyridin-1-yl)propylcarbamoyl]benzenesulfonyl fluoride |
| Molecule Weight | 517.5 |
| Molecular formula | C23H24FN5O6S |
| PubChem identifier | 155513958 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-162 | Nile Red (AC162) | 25 mg | inquiry |
| ASSD-183 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) | 100 mg | inquiry |
| ASSD-207 | NBD-X acid (AC207) | 1 g | inquiry |
| ASSD-107 | Modified Mayer's Hematoxylin (AC107) | 125 mL, 250 mL, 2×250mL | inquiry |
| ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
| ASSD-151 | Acid Fuchsin (AC151) | 25 g | inquiry |
| ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg | inquiry |
| ASSD-211 | 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) | 100 mg, 1 g | inquiry |
| ASSD-188 | Dansyl Chloride (AC188) | 1 g | inquiry |
| ASSD-173 | FITC-Dextran 70 (AC173) | 100 mg, 500 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.